[Clinical evaluation of the antioxidant activity of astragalus in women with gestational diabetes]

Nan Fang Yi Ke Da Xue Xue Bao. 2009 Jul;29(7):1402-4.
[Article in Chinese]


Objective: To evaluate the antioxidant activity of astragalus and its therapeutic effect on gestational diabetes.

Methods: Eighty-four pregnant women with gestational diabetes were divided into insulin and insulin plus astragalus groups after regular dietary control and insulin treatment to maintain stable blood glucose level. The 43 patients in insulin group received insulin injection, whereas the 41 patients in the other group received treatment with both insulin and astragalus. The SOD activity, MDA level, blood lipids and renal function were determined in both groups after the treatments.

Results: The patients with both insulin and astragalus treatments showed significantly increased serum SOD activity and decreased MDA level, renal function and blood lipids in comparison with those with exclusive insulin treatment.

Conclusion: Astragalus can effectively control blood glucose, reduce the free radicals, and promote the antioxidative activity, and may play a role in the prevention and treatment of gestational diabetes.

Publication types

  • Controlled Clinical Trial
  • English Abstract
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antioxidants / metabolism*
  • Astragalus Plant*
  • Diabetes, Gestational / drug therapy*
  • Diabetes, Gestational / metabolism*
  • Drugs, Chinese Herbal / therapeutic use*
  • Female
  • Humans
  • Malondialdehyde / metabolism
  • Oxidation-Reduction
  • Phytotherapy*
  • Pregnancy
  • Superoxide Dismutase / metabolism
  • Treatment Outcome


  • Antioxidants
  • Drugs, Chinese Herbal
  • Malondialdehyde
  • Superoxide Dismutase